Literature DB >> 1525272

Changes in argininosuccinate lyase gene expression in the rat liver during development.

M Benamar1, C Gautier, S Renouf, A Fairand, A Husson.   

Abstract

Expression of the hepatic enzyme argininosuccinate lyase (ASL), one of the urea cycle enzymes, was analyzed during the perinatal period in the rat. To this end, ASL was purified, an ELISA assay was established to quantify the enzyme protein and a cDNA clone was used to measure the amount of specific mRNA in the liver in various stages of development. During the last few days of fetal life, both enzyme and hybridizable RNA were present at levels far below those measured in the fully differentiated adult liver. Just after birth, they increased rapidly and the mRNA accumulation, particularly, could result from an enhanced rate of transcription as suggested by the experiment with actinomycin D. This postnatal shift in ASL expression was also linked to adrenal activation at birth, as shown by adrenalectomy. However, the extent to which the ASL protein accumulated after birth appeared to be limited when compared to mRNA accumulation, suggesting control mechanisms at the translational level. Thus, during the perinatal period of the rat, both transcriptional and translational control might be implicated in the expression of the ASL gene.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525272     DOI: 10.1159/000243825

Source DB:  PubMed          Journal:  Biol Neonate        ISSN: 0006-3126


  3 in total

Review 1.  Transcriptional regulation of genes for ornithine cycle enzymes.

Authors:  M Takiguchi; M Mori
Journal:  Biochem J       Date:  1995-12-15       Impact factor: 3.857

2.  Changes in levels of argininosuccinate lyase mRNA during induction by glucagon and cyclic AMP in cultured foetal-rat hepatocytes.

Authors:  S Renouf; C Buquet; A Fairand; M Benamar; A Husson
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

3.  Arginine metabolism and nitric oxide turnover in the ZSF1 animal model for heart failure with preserved ejection fraction.

Authors:  Edzard Schwedhelm; Holger Thiele; Petra Büttner; Sarah Werner; Svetlana Baskal; Dimitrios Tsikas; Volker Adams; Philipp Lurz; Christian Besler; Sarah Knauth; Martin Bahls
Journal:  Sci Rep       Date:  2021-10-19       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.